GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Agilent Technologies Inc (MEX:A) » Definitions » Capex-to-Revenue

Agilent Technologies (MEX:A) Capex-to-Revenue : 0.06 (As of Oct. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Agilent Technologies Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Agilent Technologies's Capital Expenditure for the three months ended in Oct. 2024 was MXN-1,862.92 Mil. Its Revenue for the three months ended in Oct. 2024 was MXN34,073.41 Mil.

Hence, Agilent Technologies's Capex-to-Revenue for the three months ended in Oct. 2024 was 0.06.


Agilent Technologies Capex-to-Revenue Historical Data

The historical data trend for Agilent Technologies's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilent Technologies Capex-to-Revenue Chart

Agilent Technologies Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.03 0.04 0.04 0.06

Agilent Technologies Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.05 0.07 0.06 0.06

Competitive Comparison of Agilent Technologies's Capex-to-Revenue

For the Diagnostics & Research subindustry, Agilent Technologies's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agilent Technologies's Capex-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Agilent Technologies's Capex-to-Revenue falls into.



Agilent Technologies Capex-to-Revenue Calculation

Agilent Technologies's Capex-to-Revenue for the fiscal year that ended in Oct. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-7571.869) / 130404.414
=0.06

Agilent Technologies's Capex-to-Revenue for the quarter that ended in Oct. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1862.92) / 34073.411
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Agilent Technologies  (MEX:A) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Agilent Technologies Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Agilent Technologies's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Agilent Technologies Business Description

Traded in Other Exchanges
Address
5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.